MedTrace Logo

Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00897039 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2013-09-20

No results posted yet for this study

Summary

RATIONALE: Collecting samples of tissue from patients with cancer to study in the laboratory may help doctors predict how well patients will respond to treatment with certain chemotherapy drugs and plan the best treatment.

PURPOSE: This laboratory study is looking at tumor tissue samples to predict response to chemotherapy in patients with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

Conditions

Interventions

OTHER

flow cytometry

OTHER

immunohistochemistry staining method

Sponsors & Collaborators

  • Southeastern Gynecologic Oncology

    lead OTHER

Principal Investigators

  • Vladimir D. Kravtsov, MD · Pierian Biosciences

  • Matthew O. Burrell, MD · Southeastern Gynecologic Oncology

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00897039 on ClinicalTrials.gov